Click for best price
Parenteral Drugs Market Size, Share 2023
Parenteral Drug (LVP, SVP) is defined as one intended for injection through the skin or other external boundary tissue, rather than through the alimentary canal, so that active substances they contain are administered, using gravity or force, directly into a blood vessel, organ, tissue, or lesion. They are infused when administered intravenously (IV), or injected when administered intramuscularly (IM), or subcutaneously into the human body. A large volume parenteral (LVP) is a unit dose container of greater than 100ml that is terminally sterilized by heat. Small volume parenteral (SVP) is a "catch-all" for all non-LVP parenterals products except biologicals.
This report aims to provide a comprehensive presentation of the global market for Parenteral Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Parenteral Drugs. This report contains market size and forecasts of Parenteral Drugs in global, including the following market information:
Global Parenteral Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Parenteral Drugs Market Sales, 2018-2023, 2024-2030, (K Units)
Global top five Parenteral Drugs companies in 2022 (%)
The global Parenteral Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Parenteral drugs, whether a small-molecule or biologic-based drug substance, has increased their share of the overall drug market although solid-dosage products still prevail.
We surveyed the Parenteral Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Parenteral Drugs Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Parenteral Drugs Market Segment Percentages, by Type, 2022 (%)
LVP Drug
SVP Drug
Global Parenteral Drugs Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Parenteral Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals
Medical Centers
Others
Global Parenteral Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Parenteral Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Parenteral Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Parenteral Drugs revenues share in global market, 2022 (%)
Key companies Parenteral Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Parenteral Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ostuka Pharmaceutical
Teva Pharmaceutical Industries
Kelun Pharma
Cook Pharmica
Patheon
BAG Healthcare
Beximco Pharma
Baxter Healthcare Corporation
B. Braun
Fresenius
Albert David
BML Parenteral Drugs
Pfizer (Hospira)
Pisa
Ozon Pharmaceuticals Ltd
Aspen Holdings
PSI Ltd
Wintac Limited
AXA Parenterals Ltd
Acebright
Southwest Pharmaceutical
Abbott
Outline of Major Chapters:
Chapter 1: Introduces the definition of Parenteral Drugs, market overview.
Chapter 2: Global Parenteral Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Parenteral Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Parenteral Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Parenteral Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Parenteral Drugs Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
126 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Parenteral Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Parenteral Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Parenteral Drugs Overall Market Size
2.1 Global Parenteral Drugs Market Size: 2022 VS 2030
2.2 Global Parenteral Drugs Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Parenteral Drugs Sales: 2018-2030
3 Company Landscape
3.1 Top Parenteral Drugs Players in Global Market
3.2 Top Global Parenteral Drugs Companies Ranked by Revenue
3.3 Global Parenteral Drugs Revenue by Companies
3.4 Global Parenteral Drugs Sales by Companies
3.5 Global Parenteral Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Parenteral Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Parenteral Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Parenteral Drugs Players in Global Market
3.8.1 List of Global Tier 1 Parenteral Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Parenteral Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Parenteral Drugs Market Size Markets, 2022 & 2030
4.1.2 LVP Drug
4.1.3 SVP Drug
4.2 By Type - Global Parenteral Drugs Revenue & Forecasts
4.2.1 By Type - Global Parenteral Drugs Revenue, 2018-2023
4.2.2 By Type - Global Parenteral Drugs Revenue, 2024-2030
4.2.3 By Type - Global Parenteral Drugs Revenue Market Share, 2018-2030
4.3 By Type - Global Parenteral Drugs Sales & Forecasts
4.3.1 By Type - Global Parenteral Drugs Sales, 2018-2023
4.3.2 By Type - Global Parenteral Drugs Sales, 2024-2030
4.3.3 By Type - Global Parenteral Drugs Sales Market Share, 2018-2030
4.4 By Type - Global Parenteral Drugs Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Parenteral Drugs Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Medical Centers
5.1.4 Others
5.2 By Application - Global Parenteral Drugs Revenue & Forecasts
5.2.1 By Application - Global Parenteral Drugs Revenue, 2018-2023
5.2.2 By Application - Global Parenteral Drugs Revenue, 2024-2030
5.2.3 By Application - Global Parenteral Drugs Revenue Market Share, 2018-2030
5.3 By Application - Global Parenteral Drugs Sales & Forecasts
5.3.1 By Application - Global Parenteral Drugs Sales, 2018-2023
5.3.2 By Application - Global Parenteral Drugs Sales, 2024-2030
5.3.3 By Application - Global Parenteral Drugs Sales Market Share, 2018-2030
5.4 By Application - Global Parenteral Drugs Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Parenteral Drugs Market Size, 2022 & 2030
6.2 By Region - Global Parenteral Drugs Revenue & Forecasts
6.2.1 By Region - Global Parenteral Drugs Revenue, 2018-2023
6.2.2 By Region - Global Parenteral Drugs Revenue, 2024-2030
6.2.3 By Region - Global Parenteral Drugs Revenue Market Share, 2018-2030
6.3 By Region - Global Parenteral Drugs Sales & Forecasts
6.3.1 By Region - Global Parenteral Drugs Sales, 2018-2023
6.3.2 By Region - Global Parenteral Drugs Sales, 2024-2030
6.3.3 By Region - Global Parenteral Drugs Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Parenteral Drugs Revenue, 2018-2030
6.4.2 By Country - North America Parenteral Drugs Sales, 2018-2030
6.4.3 US Parenteral Drugs Market Size, 2018-2030
6.4.4 Canada Parenteral Drugs Market Size, 2018-2030
6.4.5 Mexico Parenteral Drugs Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Parenteral Drugs Revenue, 2018-2030
6.5.2 By Country - Europe Parenteral Drugs Sales, 2018-2030
6.5.3 Germany Parenteral Drugs Market Size, 2018-2030
6.5.4 France Parenteral Drugs Market Size, 2018-2030
6.5.5 U.K. Parenteral Drugs Market Size, 2018-2030
6.5.6 Italy Parenteral Drugs Market Size, 2018-2030
6.5.7 Russia Parenteral Drugs Market Size, 2018-2030
6.5.8 Nordic Countries Parenteral Drugs Market Size, 2018-2030
6.5.9 Benelux Parenteral Drugs Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Parenteral Drugs Revenue, 2018-2030
6.6.2 By Region - Asia Parenteral Drugs Sales, 2018-2030
6.6.3 China Parenteral Drugs Market Size, 2018-2030
6.6.4 Japan Parenteral Drugs Market Size, 2018-2030
6.6.5 South Korea Parenteral Drugs Market Size, 2018-2030
6.6.6 Southeast Asia Parenteral Drugs Market Size, 2018-2030
6.6.7 India Parenteral Drugs Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Parenteral Drugs Revenue, 2018-2030
6.7.2 By Country - South America Parenteral Drugs Sales, 2018-2030
6.7.3 Brazil Parenteral Drugs Market Size, 2018-2030
6.7.4 Argentina Parenteral Drugs Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Parenteral Drugs Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Parenteral Drugs Sales, 2018-2030
6.8.3 Turkey Parenteral Drugs Market Size, 2018-2030
6.8.4 Israel Parenteral Drugs Market Size, 2018-2030
6.8.5 Saudi Arabia Parenteral Drugs Market Size, 2018-2030
6.8.6 UAE Parenteral Drugs Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Ostuka Pharmaceutical
7.1.1 Ostuka Pharmaceutical Company Summary
7.1.2 Ostuka Pharmaceutical Business Overview
7.1.3 Ostuka Pharmaceutical Parenteral Drugs Major Product Offerings
7.1.4 Ostuka Pharmaceutical Parenteral Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Ostuka Pharmaceutical Key News & Latest Developments
7.2 Teva Pharmaceutical Industries
7.2.1 Teva Pharmaceutical Industries Company Summary
7.2.2 Teva Pharmaceutical Industries Business Overview
7.2.3 Teva Pharmaceutical Industries Parenteral Drugs Major Product Offerings
7.2.4 Teva Pharmaceutical Industries Parenteral Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Teva Pharmaceutical Industries Key News & Latest Developments
7.3 Kelun Pharma
7.3.1 Kelun Pharma Company Summary
7.3.2 Kelun Pharma Business Overview
7.3.3 Kelun Pharma Parenteral Drugs Major Product Offerings
7.3.4 Kelun Pharma Parenteral Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Kelun Pharma Key News & Latest Developments
7.4 Cook Pharmica
7.4.1 Cook Pharmica Company Summary
7.4.2 Cook Pharmica Business Overview
7.4.3 Cook Pharmica Parenteral Drugs Major Product Offerings
7.4.4 Cook Pharmica Parenteral Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Cook Pharmica Key News & Latest Developments
7.5 Patheon
7.5.1 Patheon Company Summary
7.5.2 Patheon Business Overview
7.5.3 Patheon Parenteral Drugs Major Product Offerings
7.5.4 Patheon Parenteral Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Patheon Key News & Latest Developments
7.6 BAG Healthcare
7.6.1 BAG Healthcare Company Summary
7.6.2 BAG Healthcare Business Overview
7.6.3 BAG Healthcare Parenteral Drugs Major Product Offerings
7.6.4 BAG Healthcare Parenteral Drugs Sales and Revenue in Global (2018-2023)
7.6.5 BAG Healthcare Key News & Latest Developments
7.7 Beximco Pharma
7.7.1 Beximco Pharma Company Summary
7.7.2 Beximco Pharma Business Overview
7.7.3 Beximco Pharma Parenteral Drugs Major Product Offerings
7.7.4 Beximco Pharma Parenteral Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Beximco Pharma Key News & Latest Developments
7.8 Baxter Healthcare Corporation
7.8.1 Baxter Healthcare Corporation Company Summary
7.8.2 Baxter Healthcare Corporation Business Overview
7.8.3 Baxter Healthcare Corporation Parenteral Drugs Major Product Offerings
7.8.4 Baxter Healthcare Corporation Parenteral Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Baxter Healthcare Corporation Key News & Latest Developments
7.9 B. Braun
7.9.1 B. Braun Company Summary
7.9.2 B. Braun Business Overview
7.9.3 B. Braun Parenteral Drugs Major Product Offerings
7.9.4 B. Braun Parenteral Drugs Sales and Revenue in Global (2018-2023)
7.9.5 B. Braun Key News & Latest Developments
7.10 Fresenius
7.10.1 Fresenius Company Summary
7.10.2 Fresenius Business Overview
7.10.3 Fresenius Parenteral Drugs Major Product Offerings
7.10.4 Fresenius Parenteral Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Fresenius Key News & Latest Developments
7.11 Albert David
7.11.1 Albert David Company Summary
7.11.2 Albert David Parenteral Drugs Business Overview
7.11.3 Albert David Parenteral Drugs Major Product Offerings
7.11.4 Albert David Parenteral Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Albert David Key News & Latest Developments
7.12 BML Parenteral Drugs
7.12.1 BML Parenteral Drugs Company Summary
7.12.2 BML Parenteral Drugs Parenteral Drugs Business Overview
7.12.3 BML Parenteral Drugs Parenteral Drugs Major Product Offerings
7.12.4 BML Parenteral Drugs Parenteral Drugs Sales and Revenue in Global (2018-2023)
7.12.5 BML Parenteral Drugs Key News & Latest Developments
7.13 Pfizer (Hospira)
7.13.1 Pfizer (Hospira) Company Summary
7.13.2 Pfizer (Hospira) Parenteral Drugs Business Overview
7.13.3 Pfizer (Hospira) Parenteral Drugs Major Product Offerings
7.13.4 Pfizer (Hospira) Parenteral Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Pfizer (Hospira) Key News & Latest Developments
7.14 Pisa
7.14.1 Pisa Company Summary
7.14.2 Pisa Business Overview
7.14.3 Pisa Parenteral Drugs Major Product Offerings
7.14.4 Pisa Parenteral Drugs Sales and Revenue in Global (2018-2023)
7.14.5 Pisa Key News & Latest Developments
7.15 Ozon Pharmaceuticals Ltd
7.15.1 Ozon Pharmaceuticals Ltd Company Summary
7.15.2 Ozon Pharmaceuticals Ltd Business Overview
7.15.3 Ozon Pharmaceuticals Ltd Parenteral Drugs Major Product Offerings
7.15.4 Ozon Pharmaceuticals Ltd Parenteral Drugs Sales and Revenue in Global (2018-2023)
7.15.5 Ozon Pharmaceuticals Ltd Key News & Latest Developments
7.16 Aspen Holdings
7.16.1 Aspen Holdings Company Summary
7.16.2 Aspen Holdings Business Overview
7.16.3 Aspen Holdings Parenteral Drugs Major Product Offerings
7.16.4 Aspen Holdings Parenteral Drugs Sales and Revenue in Global (2018-2023)
7.16.5 Aspen Holdings Key News & Latest Developments
7.17 PSI Ltd
7.17.1 PSI Ltd Company Summary
7.17.2 PSI Ltd Business Overview
7.17.3 PSI Ltd Parenteral Drugs Major Product Offerings
7.17.4 PSI Ltd Parenteral Drugs Sales and Revenue in Global (2018-2023)
7.17.5 PSI Ltd Key News & Latest Developments
7.18 Wintac Limited
7.18.1 Wintac Limited Company Summary
7.18.2 Wintac Limited Business Overview
7.18.3 Wintac Limited Parenteral Drugs Major Product Offerings
7.18.4 Wintac Limited Parenteral Drugs Sales and Revenue in Global (2018-2023)
7.18.5 Wintac Limited Key News & Latest Developments
7.19 AXA Parenterals Ltd
7.19.1 AXA Parenterals Ltd Company Summary
7.19.2 AXA Parenterals Ltd Business Overview
7.19.3 AXA Parenterals Ltd Parenteral Drugs Major Product Offerings
7.19.4 AXA Parenterals Ltd Parenteral Drugs Sales and Revenue in Global (2018-2023)
7.19.5 AXA Parenterals Ltd Key News & Latest Developments
7.20 Acebright
7.20.1 Acebright Company Summary
7.20.2 Acebright Business Overview
7.20.3 Acebright Parenteral Drugs Major Product Offerings
7.20.4 Acebright Parenteral Drugs Sales and Revenue in Global (2018-2023)
7.20.5 Acebright Key News & Latest Developments
7.21 Southwest Pharmaceutical
7.21.1 Southwest Pharmaceutical Company Summary
7.21.2 Southwest Pharmaceutical Business Overview
7.21.3 Southwest Pharmaceutical Parenteral Drugs Major Product Offerings
7.21.4 Southwest Pharmaceutical Parenteral Drugs Sales and Revenue in Global (2018-2023)
7.21.5 Southwest Pharmaceutical Key News & Latest Developments
7.22 Abbott
7.22.1 Abbott Company Summary
7.22.2 Abbott Business Overview
7.22.3 Abbott Parenteral Drugs Major Product Offerings
7.22.4 Abbott Parenteral Drugs Sales and Revenue in Global (2018-2023)
7.22.5 Abbott Key News & Latest Developments
8 Global Parenteral Drugs Production Capacity, Analysis
8.1 Global Parenteral Drugs Production Capacity, 2018-2030
8.2 Parenteral Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Parenteral Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Parenteral Drugs Supply Chain Analysis
10.1 Parenteral Drugs Industry Value Chain
10.2 Parenteral Drugs Upstream Market
10.3 Parenteral Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Parenteral Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Parenteral Drugs in Global Market
Table 2. Top Parenteral Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Parenteral Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Parenteral Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Parenteral Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Parenteral Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Parenteral Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Parenteral Drugs Product Type
Table 9. List of Global Tier 1 Parenteral Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Parenteral Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Parenteral Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Parenteral Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Parenteral Drugs Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Parenteral Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Parenteral Drugs Sales (K Units), 2024-2030
Table 16. By Application ? Global Parenteral Drugs Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Parenteral Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Parenteral Drugs Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Parenteral Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Parenteral Drugs Sales (K Units), 2024-2030
Table 21. By Region ? Global Parenteral Drugs Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Parenteral Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Parenteral Drugs Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Parenteral Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Parenteral Drugs Sales (K Units), 2024-2030
Table 26. By Country - North America Parenteral Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Parenteral Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Parenteral Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Parenteral Drugs Sales, (K Units), 2024-2030
Table 30. By Country - Europe Parenteral Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Parenteral Drugs Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Parenteral Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Parenteral Drugs Sales, (K Units), 2024-2030
Table 34. By Region - Asia Parenteral Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Parenteral Drugs Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Parenteral Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Parenteral Drugs Sales, (K Units), 2024-2030
Table 38. By Country - South America Parenteral Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Parenteral Drugs Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Parenteral Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Parenteral Drugs Sales, (K Units), 2024-2030
Table 42. By Country - Middle East & Africa Parenteral Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Parenteral Drugs Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Parenteral Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Parenteral Drugs Sales, (K Units), 2024-2030
Table 46. Ostuka Pharmaceutical Company Summary
Table 47. Ostuka Pharmaceutical Parenteral Drugs Product Offerings
Table 48. Ostuka Pharmaceutical Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Ostuka Pharmaceutical Key News & Latest Developments
Table 50. Teva Pharmaceutical Industries Company Summary
Table 51. Teva Pharmaceutical Industries Parenteral Drugs Product Offerings
Table 52. Teva Pharmaceutical Industries Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Teva Pharmaceutical Industries Key News & Latest Developments
Table 54. Kelun Pharma Company Summary
Table 55. Kelun Pharma Parenteral Drugs Product Offerings
Table 56. Kelun Pharma Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Kelun Pharma Key News & Latest Developments
Table 58. Cook Pharmica Company Summary
Table 59. Cook Pharmica Parenteral Drugs Product Offerings
Table 60. Cook Pharmica Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Cook Pharmica Key News & Latest Developments
Table 62. Patheon Company Summary
Table 63. Patheon Parenteral Drugs Product Offerings
Table 64. Patheon Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Patheon Key News & Latest Developments
Table 66. BAG Healthcare Company Summary
Table 67. BAG Healthcare Parenteral Drugs Product Offerings
Table 68. BAG Healthcare Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. BAG Healthcare Key News & Latest Developments
Table 70. Beximco Pharma Company Summary
Table 71. Beximco Pharma Parenteral Drugs Product Offerings
Table 72. Beximco Pharma Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Beximco Pharma Key News & Latest Developments
Table 74. Baxter Healthcare Corporation Company Summary
Table 75. Baxter Healthcare Corporation Parenteral Drugs Product Offerings
Table 76. Baxter Healthcare Corporation Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Baxter Healthcare Corporation Key News & Latest Developments
Table 78. B. Braun Company Summary
Table 79. B. Braun Parenteral Drugs Product Offerings
Table 80. B. Braun Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. B. Braun Key News & Latest Developments
Table 82. Fresenius Company Summary
Table 83. Fresenius Parenteral Drugs Product Offerings
Table 84. Fresenius Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Fresenius Key News & Latest Developments
Table 86. Albert David Company Summary
Table 87. Albert David Parenteral Drugs Product Offerings
Table 88. Albert David Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. Albert David Key News & Latest Developments
Table 90. BML Parenteral Drugs Company Summary
Table 91. BML Parenteral Drugs Parenteral Drugs Product Offerings
Table 92. BML Parenteral Drugs Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. BML Parenteral Drugs Key News & Latest Developments
Table 94. Pfizer (Hospira) Company Summary
Table 95. Pfizer (Hospira) Parenteral Drugs Product Offerings
Table 96. Pfizer (Hospira) Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 97. Pfizer (Hospira) Key News & Latest Developments
Table 98. Pisa Company Summary
Table 99. Pisa Parenteral Drugs Product Offerings
Table 100. Pisa Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 101. Pisa Key News & Latest Developments
Table 102. Ozon Pharmaceuticals Ltd Company Summary
Table 103. Ozon Pharmaceuticals Ltd Parenteral Drugs Product Offerings
Table 104. Ozon Pharmaceuticals Ltd Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 105. Ozon Pharmaceuticals Ltd Key News & Latest Developments
Table 106. Aspen Holdings Company Summary
Table 107. Aspen Holdings Parenteral Drugs Product Offerings
Table 108. Aspen Holdings Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 109. Aspen Holdings Key News & Latest Developments
Table 110. PSI Ltd Company Summary
Table 111. PSI Ltd Parenteral Drugs Product Offerings
Table 112. PSI Ltd Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 113. PSI Ltd Key News & Latest Developments
Table 114. Wintac Limited Company Summary
Table 115. Wintac Limited Parenteral Drugs Product Offerings
Table 116. Wintac Limited Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 117. Wintac Limited Key News & Latest Developments
Table 118. AXA Parenterals Ltd Company Summary
Table 119. AXA Parenterals Ltd Parenteral Drugs Product Offerings
Table 120. AXA Parenterals Ltd Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 121. AXA Parenterals Ltd Key News & Latest Developments
Table 122. Acebright Company Summary
Table 123. Acebright Parenteral Drugs Product Offerings
Table 124. Acebright Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 125. Acebright Key News & Latest Developments
Table 126. Southwest Pharmaceutical Company Summary
Table 127. Southwest Pharmaceutical Parenteral Drugs Product Offerings
Table 128. Southwest Pharmaceutical Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 129. Southwest Pharmaceutical Key News & Latest Developments
Table 130. Abbott Company Summary
Table 131. Abbott Parenteral Drugs Product Offerings
Table 132. Abbott Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 133. Abbott Key News & Latest Developments
Table 134. Parenteral Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 135. Global Parenteral Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 136. Global Parenteral Drugs Production by Region, 2018-2023 (K Units)
Table 137. Global Parenteral Drugs Production by Region, 2024-2030 (K Units)
Table 138. Parenteral Drugs Market Opportunities & Trends in Global Market
Table 139. Parenteral Drugs Market Drivers in Global Market
Table 140. Parenteral Drugs Market Restraints in Global Market
Table 141. Parenteral Drugs Raw Materials
Table 142. Parenteral Drugs Raw Materials Suppliers in Global Market
Table 143. Typical Parenteral Drugs Downstream
Table 144. Parenteral Drugs Downstream Clients in Global Market
Table 145. Parenteral Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Parenteral Drugs Segment by Type in 2022
Figure 2. Parenteral Drugs Segment by Application in 2022
Figure 3. Global Parenteral Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Parenteral Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Parenteral Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. Parenteral Drugs Sales in Global Market: 2018-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Parenteral Drugs Revenue in 2022
Figure 9. By Type - Global Parenteral Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Parenteral Drugs Revenue Market Share, 2018-2030
Figure 11. By Type - Global Parenteral Drugs Sales Market Share, 2018-2030
Figure 12. By Type - Global Parenteral Drugs Price (USD/Unit), 2018-2030
Figure 13. By Application - Global Parenteral Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Parenteral Drugs Revenue Market Share, 2018-2030
Figure 15. By Application - Global Parenteral Drugs Sales Market Share, 2018-2030
Figure 16. By Application - Global Parenteral Drugs Price (USD/Unit), 2018-2030
Figure 17. By Region - Global Parenteral Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Parenteral Drugs Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Parenteral Drugs Revenue Market Share, 2018-2030
Figure 20. By Region - Global Parenteral Drugs Sales Market Share, 2018-2030
Figure 21. By Country - North America Parenteral Drugs Revenue Market Share, 2018-2030
Figure 22. By Country - North America Parenteral Drugs Sales Market Share, 2018-2030
Figure 23. US Parenteral Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Parenteral Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Parenteral Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Parenteral Drugs Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Parenteral Drugs Sales Market Share, 2018-2030
Figure 28. Germany Parenteral Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. France Parenteral Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Parenteral Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Parenteral Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Parenteral Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Parenteral Drugs Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Parenteral Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Parenteral Drugs Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Parenteral Drugs Sales Market Share, 2018-2030
Figure 37. China Parenteral Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Parenteral Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Parenteral Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Parenteral Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. India Parenteral Drugs Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Parenteral Drugs Revenue Market Share, 2018-2030
Figure 43. By Country - South America Parenteral Drugs Sales Market Share, 2018-2030
Figure 44. Brazil Parenteral Drugs Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Parenteral Drugs Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Parenteral Drugs Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Parenteral Drugs Sales Market Share, 2018-2030
Figure 48. Turkey Parenteral Drugs Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Parenteral Drugs Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Parenteral Drugs Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Parenteral Drugs Revenue, (US$, Mn), 2018-2030
Figure 52. Global Parenteral Drugs Production Capacity (K Units), 2018-2030
Figure 53. The Percentage of Production Parenteral Drugs by Region, 2022 VS 2030
Figure 54. Parenteral Drugs Industry Value Chain
Figure 55. Marketing Channels
